144 related articles for article (PubMed ID: 35680387)
21. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
[TBL] [Abstract][Full Text] [Related]
22. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
23. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
van der Goes MC; Jacobs JW; Jurgens MS; Bakker MF; van der Veen MJ; van der Werf JH; Welsing PM; Bijlsma JW
Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
[TBL] [Abstract][Full Text] [Related]
24. Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs.
Tokumoto H; Tominaga H; Arishima Y; Jokoji G; Akimoto M; Ohtsubo H; Taketomi E; Sunahara N; Nagano S; Ishidou Y; Komiya S; Setoguchi T
Nutrients; 2018 Feb; 10(2):. PubMed ID: 29463015
[TBL] [Abstract][Full Text] [Related]
25. Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort.
Wysham KD; Shofer J; Lui G; Trupin L; Andrews JS; Black DM; Graf J; Shoback DM; Katz PP
Semin Arthritis Rheum; 2022 Apr; 53():151972. PubMed ID: 35152085
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.
Matsuno H
Drugs R D; 2016 Dec; 16(4):347-353. PubMed ID: 27766589
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.
Angeli A; Guglielmi G; Dovio A; Capelli G; de Feo D; Giannini S; Giorgino R; Moro L; Giustina A
Bone; 2006 Aug; 39(2):253-9. PubMed ID: 16574519
[TBL] [Abstract][Full Text] [Related]
28. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis.
Solomon DH; Finkelstein JS; Shadick N; LeBoff MS; Winalski CS; Stedman M; Glass R; Brookhart MA; Weinblatt ME; Gravallese EM
Arthritis Rheum; 2009 Jun; 60(6):1624-31. PubMed ID: 19479876
[TBL] [Abstract][Full Text] [Related]
29. Trabecular bone score in female patients with systemic sclerosis: comparison with rheumatoid arthritis and influence of glucocorticoid exposure.
Koumakis E; Avouac J; Winzenrieth R; Toth E; Payet J; Kahan A; Allanore Y; Cormier C
J Rheumatol; 2015 Feb; 42(2):228-35. PubMed ID: 25448793
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids.
Habib GS; Haj S
Clin Rheumatol; 2005 Apr; 24(2):129-33. PubMed ID: 15372317
[TBL] [Abstract][Full Text] [Related]
31. Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy.
Loddenkemper K; Bohl N; Perka C; Burmester GR; Buttgereit F
Rheumatol Int; 2006 Feb; 26(4):331-6. PubMed ID: 15887044
[TBL] [Abstract][Full Text] [Related]
32. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
Dubois EF; Röder E; Dekhuijzen PN; Zwinderman AE; Schweitzer DH
Chest; 2002 May; 121(5):1456-63. PubMed ID: 12006428
[TBL] [Abstract][Full Text] [Related]
33. Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
Li WJ; Wang XL; Chu YR; Wang JX; Xu SQ
Clin Rheumatol; 2024 Jan; 43(1):15-22. PubMed ID: 37831335
[TBL] [Abstract][Full Text] [Related]
34. Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
Tengstrand B; Larsson E; Klareskog L; Hafström I
Scand J Rheumatol; 2007; 36(5):351-8. PubMed ID: 17963164
[TBL] [Abstract][Full Text] [Related]
35. Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target.
Bugatti S; Bogliolo L; Manzo A; De Stefano L; Delvino P; Motta F; Montecucco C
Front Immunol; 2021; 12():701922. PubMed ID: 34194443
[TBL] [Abstract][Full Text] [Related]
36. The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis.
Fassio A; Idolazzi L; Jaber MA; Dartizio C; Viapiana O; Rossini M; Gatti D
Reumatismo; 2016 Sep; 68(2):65-71. PubMed ID: 27608794
[TBL] [Abstract][Full Text] [Related]
37. [Bone mineral density in patients with rheumatoid arthritis].
Macovei L; Ancuţa C; Belibou C; Chirieac R
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):723-30. PubMed ID: 22046778
[TBL] [Abstract][Full Text] [Related]
38. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.
Carvas JS; Pereira RM; Caparbo VF; Fuller P; Silveira CA; Lima LA; Bonfa E; Mello SB
Osteoporos Int; 2010 Oct; 21(10):1723-9. PubMed ID: 19997905
[TBL] [Abstract][Full Text] [Related]
39. Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.
Florez H; Hernández-Rodríguez J; Muxi A; Carrasco JL; Prieto-González S; Cid MC; Espinosa G; Gómez-Puerta JA; Monegal A; Guañabens N; Peris P
Rheumatology (Oxford); 2020 Jul; 59(7):1574-1580. PubMed ID: 31628810
[TBL] [Abstract][Full Text] [Related]
40. Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases.
Buttgereit F; Palmowski A; Bond M; Adami G; Dejaco C
Nat Rev Rheumatol; 2024 Jul; 20(7):417-431. PubMed ID: 38831028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
